<DOC>
	<DOCNO>NCT00545831</DOCNO>
	<brief_summary>Home parenteral nutrition ( HPN ) validate technique patient various intestinal disease lead chronic malabsorption obstruction , whatever aetiology . Intravascular catheter-related bloodstream infection ( CRBSI ) frequent complication patient HPN important cause morbidity mortality patient . Moreover , CRBSI often recur first treatment catheter combination antibiotic lock catheter systemic intravenous antibiotic . In 50 % case , another CRBSI occur median delay 5 month . The aim study evaluate efficacy taurolidine lock secondary prophylaxis CRBSI recurrence HPN patient . Study population separate 2 group , first one receive Taurolock second one receiving placebo . This randomized double-blind six-month study .</brief_summary>
	<brief_title>Effect Taurolidin Prevention Bloodstream Infection</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Taurolidine</mesh_term>
	<criteria>Age superior 18 year Home parenteral nutrition tunnelized central venous catheter Bloodstream infection confirm differential hemocultures Informed consent form sign Negative BHCG test Subject unable give inform consent Pregnancy Subject two threeway catheter , nontunnelized central venous catheter Hospital related infection Central venous catheter place since less 15 day Neutropenia &lt; 500 PNN/mm3 Fungal Infection , polymicrobial need ablation central venous catheter Noresponse clinical treatment Infection Septic thrombophlebitis Chemotherapy ongoing On go malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Home Parenteral Nutrition</keyword>
	<keyword>Sepsis Prevention</keyword>
	<keyword>Central Venous Catheters</keyword>
	<keyword>Taurolidine</keyword>
</DOC>